GlassScriptPhysician profile
Anant I Patel
NPI 1295710655
$40,801.54
in general payments reported to CMS, 2019-2025
27 companies · $524 in 2025
The $524 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $7,182 · 2021: $3,197 · 2022: $8,095 · 2023: $3,244 · 2024: $5,802 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,075 · Food and Beverage: $2,780 · Travel and Lodging: $1,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,075.00 |
| Food and Beverage | $2,779.58 |
| Travel and Lodging | $1,715.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $19,751.44 | 2019-2020 | |
| Abbott Laboratories | $11,379.96 | 2021-2025 | Infinity, Proclaim |
| Medtronic, INC. | $5,937.00 | 2021-2025 | Percept PC Brainsense, Unid_pass, Intellis Adaptivestim |
| Globus Medical, INC. | $1,850.31 | 2022-2025 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System, Excelsius Gps |
| Boston Scientific Corporation | $328.27 | 2021-2024 | Vercise |
| Si-Bone, INC. | $207.94 | 2021-2024 | |
| Nuvasive, INC. | $147.49 | 2022 | |
| Saluda Medical Americas, INC. | $143.08 | 2024 | Evoke |
| Depuy Synthes Sales INC. | $119.49 | 2020-2021 | |
| Orthofix Medical, INC. | $114.57 | 2023-2025 | Cervical-Stim, Spinal-Stim, Spinal-Stim |
| Insightec,INC | $112.50 | 2022 | |
| Providence Medical Technology, INC. | $99.38 | 2025 | |
| Integra Lifesciences Corporation | $89.71 | 2023-2024 | Duraseal Exact Spinal Sealant System, Codman Hakim, Codman Certas |
| Merz North America, INC. | $85.33 | 2019 | |
| Relievant Medsystems, INC. | $55.12 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $54.25 | 2025 | Optablate |
| Arteriocyte Medical Systems, INC. | $52.66 | 2021-2023 | Magellan |
| Acumed LLC | $45.43 | 2023 | |
| Spinal Elements, INC. | $39.44 | 2023 | |
| Meticuly INC. | $35.94 | 2025 | Meticuly Patient-Specific Titanium Mesh Implant |
| Microtransponder, INC. | $29.55 | 2024 | |
| Biocomposites INC | $28.43 | 2024 | |
| Abbvie INC. | $22.48 | 2023 | |
| Olympus America INC. | $19.80 | 2023 | |
| Innovation Technologies INC | $19.50 | 2022 | |
| Spinal Simplicity, LLC | $18.60 | 2023 | Ha Minuteman G3-R |
| Core Surgical Group | $13.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anant Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.